Volume 90 Issue 20 | p. 21 | Concentrates
Issue Date: May 14, 2012

Coherus Launches, Signs A Partner

Department: Business
Keywords: biopharmaceuticals, biosimilars, process development

Coherus BioSciences has been launched to follow a new approach to producing generic biotherapeutics, or biosimilars, for global markets. A team of process development scientists with experience at several leading biotech and drug firms founded the Redwood City, Calif.-based firm. To increase speed to market and cut costs, Coherus will operate through drug development, clinical research, and manufacturing partnerships. Its first deal is with Japan’s Daiichi Sankyo to develop biosimilar versions of the autoimmune drugs etanercept and rituximab in Asia. Coherus says its pipeline includes five oncology and inflammatory disease therapeutics drugs.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment